Robert Bitterman
CHAIRMAN
Pharmaceuticals
RXi Pharmaceuticals Corp
United States of America
Biography
Mr. Bitterman currently serves as the President & CEO of Cutanea Life Sciences, Inc., a wholly owned subsidiary of Maruho Company, LTD., a specialty pharma development company focused on diseased and aging skin. Mr. Bitterman has over 18 years of executive leadership experience in the pharmaceutical and biologic life science industry. Prior to Cutanea, he served as President and CEO for Isolagen, Inc., an international, public, bioscience technology company where the primary proprietary platform used human fibroblasts for soft tissue enhancement.
Research Interest
Pharmaceutical science
